Amgen Inc. ( NASDAQ:AMGN – Get Rating ) has been given a consensus rating of 'Hold' by the eighteen analysts that are presently covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation, five have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $252.

https://www.dailypolitical.com/2023/03/10/amgen-inc-nasdaqamgn-given-consensus-recommendation-of-hold-by-brokerages.html

#dailypolitical